London calling: Californian biotech goes public in UK
This article was originally published in Scrip
Executive Summary
Verseon, a technology-based pharmaceutical company headquarter in California, has floated on the other side of the Atlantic, on London's Alternative Investment Market (AIM) – a move apparently validating London's growing life sciences strength.